These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 162873)

  • 1. Characteristics of mammary tumor cultures from four mouse strains infected with mammary tumor virus.
    Yagi MJ
    Cancer Res; 1975 Feb; 35(2):370-3. PubMed ID: 162873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of the BALB/cNIV mouse strain.
    Young LJ; DeOme KB; Blair PB; Pitelka DR; Cardiff RD
    Cancer Res; 1984 Oct; 44(10):4333-6. PubMed ID: 6088036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking of spleen cell activity against target mammary tumor cells by viral antigens.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1975 Jul; 115(1):190-4. PubMed ID: 50346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells.
    Holder WD; Peer GW; Bolognesi DP; Wells SA
    Cancer Res; 1976 Sep; 36(9 pt.1):3217-24. PubMed ID: 184944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.
    Ihle JN; Arthur LO; Fine DL
    Cancer Res; 1976 Aug; 36(8):2840-4. PubMed ID: 179709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
    Blair PB; Lane MA
    J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on mammary tumor virus detection in murine mammae cancer of strain CBA-Bln].
    Müller M; Zotter S; Wagner H; Grossmann H
    Arch Geschwulstforsch; 1971; 38(3):221-31. PubMed ID: 4335534
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of Thy 1.2 antigen expression on the surfaces of mouse mammary epithelial cells.
    Thompson K
    J Natl Cancer Inst; 1981 Jul; 67(1):143-8. PubMed ID: 6265679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic studies with mouse mammary tumor viruses: comparative studies with spontaneous mammary tumor cell vaccines from five inbred mouse strains.
    Girardi AJ; Dion AS; Holben JA
    J Natl Cancer Inst; 1985 Jan; 74(1):105-12. PubMed ID: 2982052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
    [No Abstract]   [Full Text] [Related]  

  • 15. Virus-dependent cytostatic activity to mammary tumor cells of lymphocytes from normal mice.
    Gillette RW; Lowery LT
    Cancer Res; 1976 Nov; 36(11 Pt 1):4008-14. PubMed ID: 184922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of expression and induction of mouse mammary tumor virus antigens in mouse mammary tumors.
    Hager JC; Heppner GH
    Cancer Res; 1982 Nov; 42(11):4325-9. PubMed ID: 6290031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of acquired provirus sequences in mammary tumors from low-expressor, low-risk mice.
    Altrock BW; Cardiff RD; Puma JP; Lund JK
    J Natl Cancer Inst; 1982 Jun; 68(6):1037-41. PubMed ID: 6283224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology of the mouse mammary tumor virus: comparison of mammary tumor virus with the agent found in C3Hf/Crgl mice.
    Blair PB; Weiss DW
    J Natl Cancer Inst; 1966 Mar; 36(3):423-9. PubMed ID: 18630318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural immunity in the oncornavirus-infected mouse.
    Blair PB
    Cancer Res; 1976 Feb; 36(2 pt 2):734-8. PubMed ID: 175933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal induction of mammary tumor viruses and its implications for carcinogenesis.
    McGrath CM; Jones RF
    Cancer Res; 1978 Nov; 38(11 Pt 2):4112-25. PubMed ID: 212187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.